Boron neutron capture therapy (BNCT) as a new approach for clear cell sarcoma (CCS) treatment: Trial using a lung metastasis model of CCS

  • Tooru Andoh
  • , Takuya Fujimoto
  • , Minoru Suzuki
  • , Tamotsu Sudo
  • , Yoshinori Sakurai
  • , Hiroki Tanaka
  • , Ikuo Fujita
  • , Naomasa Fukase
  • , Hiroshi Moritake
  • , Tohru Sugimoto
  • , Toshiko Sakuma
  • , Hiroshi Sasai
  • , Teruya Kawamoto
  • , Mitsunori Kirihata
  • , Yoshinobu Fukumori
  • , Toshihiro Akisue
  • , Koji Ono
  • , Hideki Ichikawa

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Abstract

Clear cell sarcoma (CCS) is a rare malignant tumor with a poor prognosis. In the present study, we established a lung metastasis animal model of CCS and investigated the therapeutic effect of boron neutron capture therapy (BNCT) using p-borono-l-phenylalanine (l-BPA). Biodistribution data revealed tumor-selective accumulation of 10B. Unlike conventional gamma-ray irradiation, BNCT significantly suppressed tumor growth without damaging normal tissues, suggesting that it may be a potential new therapeutic option to treat CCS lung metastases.

Original languageEnglish
Pages (from-to)195-201
Number of pages7
JournalApplied Radiation and Isotopes
Volume106
DOIs
Publication statusPublished - 01-12-2015
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Radiation

Fingerprint

Dive into the research topics of 'Boron neutron capture therapy (BNCT) as a new approach for clear cell sarcoma (CCS) treatment: Trial using a lung metastasis model of CCS'. Together they form a unique fingerprint.

Cite this